Caris Life Sciences (CAI) Revenue (2024 - 2026)
Caris Life Sciences (CAI) posted quarterly Revenue of $216.2 million for Q1 2026, up 78.78% year-over-year from $120.9 million in Q1 2025, and down 26.19% quarter-over-quarter from $292.9 million in Q4 2025.
Caris Life Sciences (CAI) Revenue (2024 - 2026) Analysis & Trends
Caris Life Sciences' Revenue history runs 3 years deep, the most recent figure standing at $216.2 million for Q1 2026.
- In Q1 2026, Revenue rose 78.78% year-over-year to $216.2 million; the TTM figure through Mar 2026 stood at $907.3 million (up 100.51% YoY), while the FY2025 annual figure was $812.0 million, up 96.97% from the prior year.
- Revenue for Q1 2026 stood at $216.2 million, down from $292.9 million in the prior quarter.
- The five-year high for Revenue was $292.9 million in Q4 2025, with the low at $100.0 million in Q2 2024.
- The 3-year median for Revenue is $155.7 million (2024), against an average of $170.0 million.
- The sharpest annual moves came in 2025 and 2026: Revenue surged 125.44% in 2025, then soared 78.78% in 2026.
- Caris Life Sciences' Revenue stood at $129.9 million in 2024, then jumped by 125.44% to $292.9 million in 2025, then slipped by 26.19% to $216.2 million in 2026.
- Business Quant data shows CAI's Revenue at $216.2 million in Q1 2026, $292.9 million in Q4 2025, and $216.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Caris Life Sciences | 6.16 Bn | 5.37 Bn | 182.38 Mn | 263.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 263.71 Mn |
| Mar 31, 2026 | 216.17 Mn |
| Dec 31, 2025 | 292.89 Mn |
| Sep 30, 2025 | 216.83 Mn |
| Jun 30, 2025 | 181.40 Mn |
| Mar 31, 2025 | 120.92 Mn |
| Dec 31, 2024 | 129.92 Mn |
| Sep 30, 2024 | 101.62 Mn |
| Jun 30, 2024 | 100.05 Mn |